Semnur Pharmaceuticals, a wholly owned subsidiary of Scilex Holding Company, will go public via a merger with special purpose acquisition company Denali Capital Acquisition Corp in a $2.5 billion deal, the companies...
Fairfax, Bain look to buy Gujarat API company Farmson
Canadian billionaire Prem Watsa’s Fairfax Group and Bain Capital are vying for a buyout of Vadodara-based active pharmaceuticals ingredient (API) maker Farmson Basic Drugs in a deal valuing the company at ₹4,000...
Zydus Lifesciences acquires 50% stake in Sterling Biotech
Zydus Lifesciences said it has entered into an agreement with Temasek-backed Perfect Day to acquire a 50 percent stake in Sterling Biotech. Post the transaction, Sterling Biotech will become a 50:50 joint venture (JV)...
Torrent, Zydus, EQT set to make the cut for $3 bn JB Chemicals buyout
Torrent Pharma and Zydus Lifesciences are set to battle it out for JB Chemicals and Pharmaceuticals, the fifth and the sixth largest Indian drugmakers, along with possibly EQT and others, said people with knowledge of...
Roche considering divesting $1.9 bln cancer data startup, FT reports
Swiss pharmaceutical company Roche is considering divesting cancer data specialist Flatiron Health, the Financial Times reported on Wednesday, citing people familiar with the matter. Roche had paid $1.9 billion for New...
Strides Pharma Science announces acquisition of balance stake in Strides Global Consumer Healthcare, UK
Strides Arcolab International (SAIL UK), a wholly owned subsidiary of Strides Pharma Science in UK, proposes to acquire balance stake in Strides Global Consumer Healthcare (Consumer UK) from the existing Investor...
Semnur Pharmaceuticals to go public in SPAC deal of up to $2 billion with Denali Capital
Drug developer Semnur Pharmaceuticals said on Tuesday it has signed a letter of intent to go public through a merger with special purpose acquisition company Denali Capital Acquisition Corp in a pre-transaction equity...
Blackstone selling Japan drugmaker Alinamin to MBK Partners
Blackstone and MBK Partners said on Wednesday the U.S. private equity firm is selling Japanese drugmaker Alinamin Pharmaceutical to the North Asian buyout fund. The deal size would be 350 billion yen ($2.17 billion), a...
South Korea’s SK Bioscience to buy control of Germany’s IDT Biologika for $244 mln
SK Bioscience will acquire a 60% stake in German pharmaceutical contract manufacturing firm IDT Biologika GmbH from Klocke Gruppe in a deal worth 339 billion won ($243.75 million), the South Korean vaccine maker said on...
Jashvik Capital buys into Futura Surgicare
Jashvik Capital, an India-based private equity firm, has acquired a minority stake in Futura Surgicare, a Bangalore-based medical products, consumables and devices player, stated a press release. Established in 1994 by...
Sun Pharma completes merger of Taro
Sun Pharma on Monday announced the completion of the merger of Taro Pharmaceutical Industries Ltd. with its subsidiary. As part of this merger, Sun Pharma acquired all outstanding ordinary shares of Taro other than the...
Vanda rejects Future Pak and Cycle Pharma’s takeover offers
Vanda Pharmaceuticals said on Wednesday that it has rejected takeover offers from UK-based Cycle Pharmaceutical and a revised bid from contract manufacturer Future Pak, adding that both offers undervalue the U.S...
